78 related articles for article (PubMed ID: 3026101)
21. [Molsidomine in exertion angina].
Witchitz S; Kolsky H; Moisson P
Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):539-43. PubMed ID: 6689396
[TBL] [Abstract][Full Text] [Related]
22. [Effects of molsidomine during the cold test in stable coronary insufficiency under beta-blocker treatment].
Zygelman M; Neukirch F; Mérillon JP; Dahan M; Trouillet JL; Juliard JM; Pansard Y; Gourgon R
Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1383-9. PubMed ID: 6150693
[TBL] [Abstract][Full Text] [Related]
23. Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.
Visser CA; Jaarsma W; Kan G; Lie KI
Postgrad Med J; 1984; 60 Suppl 4():17-20. PubMed ID: 6527974
[TBL] [Abstract][Full Text] [Related]
24. Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
Dorow P; Schiess W
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):419-22. PubMed ID: 6386704
[TBL] [Abstract][Full Text] [Related]
25. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of the acute hemodynamic effect of nisoldipine (Bay k 5552) and nifedipine in patients with ischemia-induced left ventricular impaired function].
Aschenberg W; Nienaber C; Spielmann R; Bleifeld W
Z Kardiol; 1988 Apr; 77(4):238-44. PubMed ID: 3291444
[TBL] [Abstract][Full Text] [Related]
27. A comparison of nifedipine and isosorbide dinitrate in angina pectoris with particular reference to arterial oxygen saturation.
Tirlapur VG; Mir MA
Postgrad Med J; 1983; 59 Suppl 2():30-4. PubMed ID: 6136959
[TBL] [Abstract][Full Text] [Related]
28. Assessment of sublingual isosorbide dinitrate and intracoronary nifedipine during ergonovine provocation.
Bethge HD; Bachmann K
Z Kardiol; 1983; 72 Suppl 3():92-7. PubMed ID: 6666236
[TBL] [Abstract][Full Text] [Related]
29. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
Reiniger G; Blasini R; Brügmann U; Rudolph W
Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
[TBL] [Abstract][Full Text] [Related]
30. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
Mahgoub AA; El-Medany AH; Abdulatif AS
Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
[TBL] [Abstract][Full Text] [Related]
31. Hemodynamic measurements and exercise testing to assess the development of tolerance against slow-release isosorbide dinitrate.
Weidemann H; Schuon J; Schober B
Z Kardiol; 1983; 72 Suppl 3():229-32. PubMed ID: 6666226
[TBL] [Abstract][Full Text] [Related]
32. [Studies on the influence of Molsidomin on coronary heart disease (author's transl)].
Jansen E; Klepzig H
Med Klin; 1976 Nov; 71(47):2072-6. PubMed ID: 1004355
[TBL] [Abstract][Full Text] [Related]
33. [The association of amlodipine with isosorbide-5-mononitrate in the treatment of ischemic-hypertensive cardiopathy].
Palazzuoli V; Mondillo S; Faglia S; D'Aprile N; Kristodhullo A
Clin Ter; 1992 Jul; 141(7):9-14. PubMed ID: 1387055
[TBL] [Abstract][Full Text] [Related]
34. Radionuclear measurement of peripheral hemodynamics in selection of vasodilators for treatment of heart failure.
Todo Y; Ohyanagi M; Fujisue R; Iwasaki T
J Nucl Med; 1988 Apr; 29(4):451-9. PubMed ID: 3351600
[TBL] [Abstract][Full Text] [Related]
35. Effects of long-term treatment with 120 mg of sustained-release isosorbide dinitrate and 60 mg of sustained-release nifedipine on myocardial perfusion.
Stegaru B; Loose R; Keller H; Buss J; Wetzel E
Am J Cardiol; 1988 Mar; 61(9):74E-77E. PubMed ID: 3348141
[TBL] [Abstract][Full Text] [Related]
36. Comparison of haemodynamic effects of nifedipine and molsidomine in patients with coronary artery disease.
Kyriakidis M; Vyssoulis G; Sfikakis P; Kyriakidis C; Pitsavos C; Valsamis K; Nomikos V; Toutouzas P
Eur J Clin Pharmacol; 1989; 37(5):443-7. PubMed ID: 2598982
[TBL] [Abstract][Full Text] [Related]
37. [Cordipine in the treatment of patients with exacerbated coronary disease].
Musiał W; Bolińska H; Pracka H; Polak-Słaboszewska D
Wiad Lek; 1989 Feb; 42(4):205-9. PubMed ID: 2576167
[TBL] [Abstract][Full Text] [Related]
38. Anti-ischemic effects of slow-release formulations of nifedipine, isosorbide-5-mononitrate and their combination in patients with coronary heart disease.
Erlemeier HH; Kupper W; Hempel NB; Bleifeld W
Cardiology; 1988; 75(6):409-18. PubMed ID: 3228824
[TBL] [Abstract][Full Text] [Related]
39. [Modification of physical fitness of patients with coronary heart disease with nifedipine during a stay at altitude].
Deuber HJ
Wien Med Wochenschr; 1990 Aug; 140(16):417-21. PubMed ID: 2238649
[TBL] [Abstract][Full Text] [Related]
40. [Comparative ergometric tests in coronary disease patients under betasympathicolysis using Betadrenol and Isoket].
Raff U; Jeschke D
Med Welt; 1977 Sep; 28(38):1518-21. PubMed ID: 20547
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
